Concepedia

Author

Richard Klar

Hikma Pharmaceuticals (Germany)ORCID

Also Known As

K Richard, Klar Richard, R Klar, R. Klar, Richard Klar

73

Publications

1.3K

Citations

14

H-Index

12

Concepts

All Affiliations

Hikma Pharmaceuticals (Germany)Technical University of MunichKlinikum rechts der IsarHeidelberg UniversityDeutschen Konsortium für Translationale Krebsforschung
RK

About

Richard Klar is an author at Hikma Pharmaceuticals (Germany) specializing in medicine, immunotherapy, and hematology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

47

2

Natural Sciences

1

1

23

3

Biomolecular Engineering

1

1

24

4

Cell Biology

1

1

23

5

Immunology

1

1

24

Richard Klar

×

16

Publications

1.2K

Citations

13

H-Index

YearCitations

Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry

Michal Bassani‐Sternberg, Eva Bräunlein, Richard Klar,

Nature Communications

2016

698

ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression

Yu Cao, Jimena Trillo-Tinoco, Rosa A. Sierra,

Nature Communications

2019

150

Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity

Abhishek S. Kashyap, Tamara Thelemann, Richard Klar,

Journal for ImmunoTherapy of Cancer

2019

59

Immuno-PET Imaging of Engineered Human T Cells in Tumors

Sabine Mall, Nahid Yusufi, Ricarda Wagner,

Cancer Research

2016

56

Therapeutic Targeting of Metadherin Suppresses Colorectal and Lung Cancer Progression and Metastasis

Minhong Shen, Shanshan Xie, Michelle Rowicki,

Cancer Research

2020

50

In-depth Characterization of a TCR-specific Tracer for Sensitive Detection of Tumor-directed Transgenic T Cells by Immuno-PET

Nahid Yusufi, Sabine Mall, Henrique Bianchi,

Theranostics

2017

33

Transgenic antigen-specific, HLA-A*02:01-allo-restricted cytotoxic T cells recognize tumor-associated target antigen STEAP1 with high specificity

David Schirmer, Thomas G. P. Grünewald, Richard Klar,

OncoImmunology

2016

32

Human HLA-A*02:01/CHM1+ allo-restricted T cell receptor transgenic CD8+ T Cells specifically inhibit Ewing sarcoma growth<i>in vitro</i>and<i>in vivo</i>

Franziska Blaeschke, Uwe Thiel, A. Kirschner,

Oncotarget

2016

27

Therapeutic targeting of naturally presented myeloperoxidase-derived HLA peptide ligands on myeloid leukemia cells by TCR-transgenic T cells

Richard Klar, Sebastian Johannes Schober, Martina Rami,

Leukemia

2014

24

Using RNA-seq to Assess Off-Target Effects of Antisense Oligonucleotides in Human Cell Lines

Sven Michel, Ksenija Schirduan, Yimin Shen,

Molecular Diagnosis & Therapy

2020

23

Page 1